Gull Laboratories, Inc.: FDA filings under this applicant name
FDA lists 57 510(k) clearances under the applicant name “Gull Laboratories, Inc.” (first 1977, latest 1999), across 29 product codes in 3 review panels. Median 510(k) review time under this name: 97 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LGC | Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific | 7 | 7 |
| LGD | Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii | 6 | 6 |
| LFX | Enzyme Linked Immunoabsorbent Assay, Rubella | 5 | 5 |
| LFZ | Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus | 4 | 4 |
| LSE | Epstein-Barr Virus, Other | 3 | 3 |
| GLZ | Antigens, If, Toxoplasma Gondii | 2 | 2 |
| GNW | Antisera, Cf, Influenza Virus A, B, C | 2 | 2 |
| GQI | Antiserum, Cf, Cytomegalovirus | 2 | 2 |
| GQL | Antisera, Fluorescent, Herpesvirus Hominis 1,2 | 2 | 2 |
| GQX | Antiserum, Cf, Varicella-Zoster | 2 | 2 |
Plus 19 more product codes.
Review panels
- Microbiology (54)
- Immunology (2)
- Dental (1)
Most recent Gull Laboratories, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K983541 | HSV 1+2 IGG ELISA TEST | LGC | 1999-02-26 | 140 |
| K971857 | MUMPS IGG ELISA TESTY | LJY | 1997-11-04 | 168 |
| K962343 | TOXO IGG ELISA TEST | LGD | 1997-03-24 | 279 |
| K935730 | EBNA IGG ELISA TEST | LLM | 1995-09-19 | 657 |
| K940093 | EBV-EA(D) IGG ELISA TEST | LSE | 1995-09-15 | 616 |
| K941046 | VZV IGG ELISA TEST | LFY | 1995-08-24 | 535 |
| K941198 | EBV LGG ELISA TEST | LSE | 1995-08-23 | 527 |
| K932333 | PROTECTORAL ULTRASONIC HANDPIECE PROCESSOR | EFB | 1995-08-15 | 824 |
| K941624 | RUBELLA IGG ELISA TEST | LFX | 1995-08-04 | 487 |
| K922759 | HSV-2 IGM ELISA TEST--MODIFICATION | LGC | 1992-10-05 | 119 |
47 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Gull Laboratories, Inc..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Gull Laboratories, Inc. (a text match, not an official crosswalk):
- G0008 — Administration of influenza virus vaccine (via GNW)
- Q2039 — Influenza virus vaccine, not otherwise specified (via GNW)
- Q2034 — Influenza virus vaccine, split virus, for intramuscular use (agriflu) (via GNW)
Frequently asked questions
How many FDA 510(k) clearances are listed under Gull Laboratories, Inc.?
FDA lists 57 510(k) clearances under the applicant name “Gull Laboratories, Inc.” (first 1977, latest 1999), across 29 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Gull Laboratories, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Gull Laboratories, Inc. is 97 days.
Which FDA product codes appear under Gull Laboratories, Inc.?
The most frequent FDA product codes under this applicant name are LGC (Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-Specific, 7); LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii, 6); LFX (Enzyme Linked Immunoabsorbent Assay, Rubella, 5).
Next steps
- See all 57 Gull Laboratories, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LGC, Gull Laboratories, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.